Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos (NYSE: GKOS), a company specializing in ophthalmic pharmaceutical and medical technology, has announced its participation in five major investor conferences in late 2024. The schedule includes appearances at the Stifel Healthcare Conference (Nov 19), Stephens Annual Investment Conference (Nov 20), BTIG Ophthalmology Day (Dec 2), Piper Sandler Annual Healthcare Conference (Dec 4), and Citi Global Healthcare Conference (Dec 5). Live and archived webcasts of these events will be accessible through the company's investor relations website.
Glaukos (NYSE: GKOS), un'azienda specializzata in tecnologia medica e farmaceutica oftalmica, ha annunciato la sua partecipazione a cinque importanti conferenze per investitori nella fine del 2024. Il programma include le apparizioni alla Stifel Healthcare Conference (19 novembre), alla Stephens Annual Investment Conference (20 novembre), al BTIG Ophthalmology Day (2 dicembre), alla Piper Sandler Annual Healthcare Conference (4 dicembre) e alla Citi Global Healthcare Conference (5 dicembre). I webcast in diretta e quelli registrati di questi eventi saranno accessibili attraverso il sito web delle relazioni con gli investitori dell'azienda.
Glaukos (NYSE: GKOS), una empresa especializada en tecnología médica y farmacéutica oftálmica, ha anunciado su participación en cinco importantes conferencias para inversores a finales de 2024. El calendario incluye apariciones en la Stifel Healthcare Conference (19 de noviembre), la Stephens Annual Investment Conference (20 de noviembre), el BTIG Ophthalmology Day (2 de diciembre), la Piper Sandler Annual Healthcare Conference (4 de diciembre) y la Citi Global Healthcare Conference (5 de diciembre). Las retransmisiones en vivo y grabadas de estos eventos estarán disponibles a través del sitio web de relaciones con inversores de la empresa.
글라우코스 (NYSE: GKOS)는 안과 제약 및 의료 기술 전문 기업으로서 2024년 말에 다섯 개의 주요 투자자 컨퍼런스에 참여할 예정이라고 발표했습니다. 일정에는 Stifel Healthcare Conference (11월 19일), Stephens Annual Investment Conference (11월 20일), BTIG Ophthalmology Day (12월 2일), Piper Sandler Annual Healthcare Conference (12월 4일), 그리고 Citi Global Healthcare Conference (12월 5일)가 포함되어 있습니다. 이러한 이벤트의 실시간 및 기록된 웹캐스트는 회사의 투자자 관계 웹사이트를 통해 접근할 수 있습니다.
Glaukos (NYSE: GKOS), une entreprise spécialisée dans les technologies médicales et pharmaceutiques ophtalmiques, a annoncé sa participation à cinq importantes conférences pour investisseurs à la fin de 2024. Le calendrier comprend des apparitions à la Stifel Healthcare Conference (19 novembre), à la Stephens Annual Investment Conference (20 novembre), au BTIG Ophthalmology Day (2 décembre), à la Piper Sandler Annual Healthcare Conference (4 décembre) et à la Citi Global Healthcare Conference (5 décembre). Des webcasts en direct et enregistrés de ces événements seront accessibles via le site web des relations avec les investisseurs de l'entreprise.
Glaukos (NYSE: GKOS), ein Unternehmen, das sich auf ophthalmologische Pharmazeutika und Medizintechnik spezialisiert hat, hat die Teilnahme an fünf wichtigen Investorenkonferenzen Ende 2024 bekannt gegeben. Der Zeitplan umfasst Auftritte bei der Stifel Healthcare Conference (19. November), der Stephens Annual Investment Conference (20. November), dem BTIG Ophthalmology Day (2. Dezember), der Piper Sandler Annual Healthcare Conference (4. Dezember) und der Citi Global Healthcare Conference (5. Dezember). Live- und aufgezeichnete Webcasts dieser Veranstaltungen werden über die Investor-Relations-Website des Unternehmens zugänglich sein.
- None.
- None.
-
Stifel Healthcare Conference on Tuesday, November 19, 2024, at 12:40 p.m. ET in
New York City , NY -
Stephens Annual Investment Conference on Wednesday, November 20, 2024, at 10:00 a.m. ET in
Nashville, TN - BTIG Ophthalmology Day on Monday, December 2, 2024, at 4:40 p.m. ET (Virtual)
-
Piper Sandler Annual Healthcare Conference on Wednesday, December 4, 2024, at 1:00 p.m. ET in
New York City , NY -
Citi Global Healthcare Conference on Thursday, December 5, 2024, at 9:30 a.m. ET in
Miami, FL
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012. In 2024, Glaukos commenced commercial launch activities for iDose® TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical designed to deliver 24/7 glaucoma drug therapy inside the eye for extended periods of time. Glaukos also markets the only FDA-approved corneal cross-linking therapy utilizing a proprietary bio-activated pharmaceutical for the treatment of keratoconus, a rare corneal disorder. Glaukos continues to successfully develop and advance a robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241108318039/en/
Chris Lewis
Vice President, Investor Relations & Corporate Affairs
(949) 481-0510
clewis@glaukos.com
Source: Glaukos Corporation
FAQ
What investor conferences will Glaukos (GKOS) attend in November-December 2024?
Where can I watch Glaukos (GKOS) investor conference presentations in 2024?
Which of the Glaukos (GKOS) investor conferences in 2024 will be virtual?
What time is Glaukos (GKOS) presenting at the Stifel Healthcare Conference 2024?
